{"transactions":[{"id":2421400,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":130998,"kind":"person","name":"GALLOWAY CHRISTOPHER D","position":1,"cik":"0001829319","reported_name":"GALLOWAY CHRISTOPHER D","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T11:06:09.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":305743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022."}],"balance_after":305743,"derivative":{"exercise_price":0.24,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":305743},"source":{"system":"sec-edgar","filing":"0001437749-22-001915","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922001915/rdgdoc.xml","form_type":"4"}},{"id":2809455,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":130998,"kind":"person","name":"GALLOWAY CHRISTOPHER D","position":1,"cik":"0001829319","reported_name":"GALLOWAY CHRISTOPHER D","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-05T00:32:54.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":81537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The amount reported reflects the maximum number of shares of common stock underlying the award that may vest based upon the achievement of specified performance metrics. The vesting of such shares is contingent upon the timely and successful achievement during the year ending December 31, 2021 of certain performance milestones related to the Issuer's planned clinical trials, with the vesting of one-third (1/3) of the total shares tied to each such milestone. If any such milestone is achieved, one-third (1/3) of the shares tied to such milestone (i.e. one-ninth (1/9) of the total shares underlying the award) will vest immediately and the remainder of the shares tied to such milestone (i.e. two-ninths (2/9) of the total shares underlying the award) will vest in 24 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 24-month period commencing January 31, 2022. In order for all shares underlying the award to vest, all three milestones mus"}],"balance_after":81537,"derivative":{"exercise_price":1.11,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":81537},"source":{"system":"sec-edgar","filing":"0001437749-21-005058","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921005058/rdgdoc.xml","form_type":"4"}},{"id":2809454,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":130998,"kind":"person","name":"GALLOWAY CHRISTOPHER D","position":1,"cik":"0001829319","reported_name":"GALLOWAY CHRISTOPHER D","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-05T00:32:54.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":27180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing March 31, 2021."}],"balance_after":27180,"derivative":{"exercise_price":1.11,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":27180},"source":{"system":"sec-edgar","filing":"0001437749-21-005058","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921005058/rdgdoc.xml","form_type":"4"}},{"id":3002372,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":130998,"kind":"person","name":"GALLOWAY CHRISTOPHER D","position":1,"cik":"0001829319","reported_name":"GALLOWAY CHRISTOPHER D","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-22T00:04:55.000Z","date":"2020-10-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"In connection with the Reporting Person's new employment with the Issuer, the Compensation Committee of the Issuer's Board of Directors approved the grant of non-qualified stock options to the Reporting Person.  The grant was made as an inducement material to the Reporting Person's acceptance of employment with the Issuer, in accordance with NASDAQ Listing Rule 5635(c)(4)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 36-month period beginning November 30, 2020."}],"balance_after":200000,"derivative":{"exercise_price":0.85,"expiration_date":"2030-10-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-20-021435","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920021435/rdgdoc.xml","form_type":"4"}}]}